Skip to main content
SDGR logo

SDGR

Schrodinger, Inc.
$16.49 -0.51 (-3.00%) At close · Jul 7
Market Cap
$1.23B
Shares
74,720,724

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$255.87M +23.3%
FY2025 Revenue FY2019–FY2025
Net Income
-$103.27M +44.8%
FY2025 Net Income FY2019–FY2025
Gross Margin
55.74% -7.9pp
FY2025 Gross Margin FY2019–FY2025
Operating Margin
-65.23% +35.6pp
FY2025 Operating Margin FY2019–FY2025
Diluted EPS
-$1.41 +45.1%
FY2025 Diluted EPS FY2020–FY2025
Operating Cash Flow
$13.9M +108.8%
FY2025 Operating Cash Flow FY2019–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
$254.91M $255.87M $207.54M $216.67M $180.96M $137.93M $108.1M $85.54M
$113.87M $113.26M $75.46M $75.97M $79.93M $72.31M $44.62M $36.45M
$141.04M $142.61M $132.08M $140.69M $101.02M $65.62M $63.47M $49.09M
55.74% 63.64% 64.93% 55.83% 47.57% 58.72% 57.39%
$171.12M $173.14M $201.79M $181.77M $126.37M $90.9M $64.7M $39.4M
$42.2M $40.96M $39.92M $37.23M $30.64M $22.15M $17.8M $21.36M
$92.52M $95.41M $99.68M $99.15M $90.83M $64.01M $41.9M $27.04M
$587K $513K $0
$6.02M $6.16M $5.55M $4.34M $2.85M $3.66M $3.64M
$305.84M $309.51M $341.38M $318.14M $247.84M $177.06M $124.39M $87.81M
-$164.8M -$166.9M -$209.3M -$177.45M -$146.82M -$111.44M -$60.92M -$38.72M
-65.23% -100.85% -81.9% -81.13% -80.8% -56.35% -45.26%
-$160.87M -$203.14M -$171.9M -$142.47M -$108.6M -$57.26M -$35.08M
$3.95M $1.06M $2.25M $1.88M
$62.64M $64.57M $23.59M $220.37M -$2.31M $10.64M $34.62M $12.74M
$0 $0 $147.21M $11.83M -$1.78M $4.11M $943K
-$102.16M -$102.33M -$185.71M $42.92M -$149.12M -$100.81M -$26.29M -$25.97M
$1.32M $939K $1.41M $2.2M $63K $411K $345K -$291K
-$103.48M -$103.27M -$187.12M $40.72M -$149.19M -$100.39M -$24.46M -$24.57M
-40.36% -90.16% 18.79% -82.44% -72.78% -22.63% -28.72%
$0 -$3000 -$826K -$2.17M -$1.11M
-$103.6M -$103.38M -$187.18M $43.38M -$150.92M -$101.36M -$24.16M -$24.55M
USD/shares -$1.41 -$2.57 $0.57 -$2.10 -$1.42 -$0.41
USD/shares -$1.41 -$2.57 $0.54 -$2.10 -$1.42 -$0.41
shares 73.44M 72.67M 71.78M 71.17M 70.59M 60.02M 6M
shares 73.44M 72.67M 74.99M 71.17M 70.59M 60.02M 6M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Software Segment $199,500,000 $180,365,000 $159,124,000 $135,578,000 $113,236,000 $92,530,000 $66,735,000
Drug Discovery Segment $56,369,000 $27,174,000 $57,542,000 $45,377,000 $24,695,000 $15,565,000 $18,808,000

By Geography (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
United States $152,963,000 $114,869,000 $161,961,000 $123,556,000 $90,398,000 $60,737,000 $47,622,000
EMEA $75,164,000 $65,650,000 $29,135,000 $34,451,000 $28,880,000
APAC $26,181,000 $25,802,000 $24,569,000 $21,680,000 $17,778,000
Non Us $1,561,000 $1,218,000 $1,001,000 $1,268,000 $875,000 $8,430,000 $6,050,000
Japan $14,558,000 $14,367,000
Europe $24,370,000 $17,504,000

By Product & Service (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Software Products and Services $199,500,000 $180,365,000 $159,124,000 $135,578,000 $113,236,000 $92,530,000 $66,735,000
Revenue From Contract With Customer Before Software Contribution $183,512,000 $172,349,000 $157,324,000 $134,578,000 $112,236,000 $91,530,000 $66,735,000
On Premise Software $101,448,000 $104,020,000 $104,511,000 $84,487,000 $74,598,000 $58,311,000 $42,647,000
Drug Discovery $56,369,000 $27,174,000 $57,542,000 $45,377,000 $24,695,000 $15,565,000 $18,808,000
Drug Discovery Services $54,760,000 $25,143,000 $54,720,000 $43,427,000
Hosted Software $45,123,000 $35,253,000 $20,381,000 $14,890,000 $11,076,000 $9,192,000 $7,418,000
Maintenance $27,293,000 $23,279,000 $23,066,000 $19,996,000 $17,294,000 $14,465,000 $11,643,000
Professional Services $9,648,000 $9,797,000 $9,366,000 $15,205,000 $9,268,000 $9,562,000 $5,027,000
Drug Discovery Services Revenue From Contracts With Customers $43,427,000 $24,584,000 $15,565,000
Software Contribution $1,800,000 $1,000,000 $1,000,000 $1,000,000
Key facts CIK 1490978 CUSIP 80810D103 13F (30d) 6 filings 6 filers Visit website Investor relations